Easing mRNA Manufacturing Bottlenecks – Panel Discussion Highlights Part 1

Following the global pandemic and success of mRNA technology in vaccines immunizing against severe COVID-19 infections, a panel of experts from BioNTech, Sanofi, eTheRNA, IAVI and TriLink Biotechnologies came together to discuss how industry can ease the bottlenecks that currently exist to wider usage of mRNA. The first of two podcast episodes featuring highlights will focus on strengthening supply chains, drug substance and drug product manufacturing.